Childhood onset systemic sclerosis: Classification, clinical and serologic features, and survival in comparison with adult onset disease

Journal of Rheumatology

Volumn 33, Issue 5, 2006, Pages 1004-1013

  Scalapino, Kenneth ^a   Arkachaisri, Thaschawee ^b   Lucas, Mary ^b   Fertig, Noreen ^b   Helfrich, David J ^b   Londino Jr , Aldo V ^b   Steen, Virginia D ^b   Medsger Jr , Thomas A ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Pediatrics ^*

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Autoantibodies; Childhood; Scleroderma; Systemic sclerosis

Indexed keywords

CENTROMERE ANTIBODY; DNA DIRECTED RNA POLYMERASE III; PM SCL ANTIBODY; RIBONUCLEOPROTEIN ANTIBODY; U1 RNP ANTIBODY; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CAUSE OF DEATH; CHILD; CHILDHOOD DISEASE; CHILDHOOD ONSET SYSTEMIC SCLEROSIS; DERMATOMYOSITIS; DISEASE CLASSIFICATION; EVALUATION; FEMALE; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOPATHY; ONSET AGE; POLYMYOSITIS; PRIORITY JOURNAL; SERODIAGNOSIS; SKINFOLD THICKNESS; STATISTICAL SIGNIFICANCE; SURVIVAL; SYMPTOMATOLOGY; SYSTEMIC SCLEROSIS;

ADULT; AGE OF ONSET; AUTOANTIBODIES; AUTOANTIGENS; DERMATOMYOSITIS; DNA TOPOISOMERASES, TYPE I; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; RNA POLYMERASE III; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE;

EID: 33646438955     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Silver RM, Medsger TA Jr, Bolster MB. Systemic sclerosis and scleroderma variants: clinical aspects. In: Koopman WJ, Moreland LW, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001:1590-624.
2. LeRoy EC, Medsger TA Jr. Criteria for the classification of early systemic sclerosis. J Rheumatol 2001;28:1573-6.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (parts 1 and 2). N Engl J Med 1975;292:344-7; 403-7.
4. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
5. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
6. Clements P, Lachenbruch P, Seibold J, et al. Inter- and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995;22:1281-5.
7. Kao AH, Lacomis D, Lucas M, Fertig N, Oddis CV. Anti-signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy. Arthritis Rheum 2004;50:209-15.
8. Mitri GM, Lucas M, Fertig N, Steen VD, Medsger TA Jr. A comparison between anti-Th/To and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvement. Arthritis Rheum 2003;48:203-9.
9. Gunduz OH, Fertig N, Lucas M, Medsger TA Jr. Systemic sclerosis with renal crisis and pulmonary hypertension. Arthritis Rheum 2001;44:1663-6.
10. Masi AT, Rodnan GP, Medsger TA Jr, et al. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980;23:581-90.
11. Vayssairat M, Baudot N, Abuaf N. Long-term follow-up study of 184 patients with definite systemic sclerosis: classification considerations. Clin Rheumatol 1992;11:356-63.
12. Scussel-Lonzetti LS, Joyal F, Raynauld J-P, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
13. Kass H, Hanson V, Patrick J. Scleroderma in childhood. J Peds 1966;68:243-56.
14. Kornreich HK, King KK, Bernstein BH, Singsen BH, Hanson V Scleroderma in childhood. Arthritis Rheum 1977;20:343-50.
15. Medsger TA Jr, Masi AT. Epidemiology of progressive systemic sclerosis. Clin Rheum Dis 1979;5:15-25.
16. Tuffanelli DL, Winkelmann RK. Systemic scleroderma, a clinical study of 727 cases. Arch Dermatol 1961;84:359-71.
17. Barnett AJ, Coventry DA. Scleroderma. 1. Clinical features, course of illness and response to treatment in 61 cases. Med J Aust 1969; 1:992-1001.
18. Blaszczyk M, Janniger CK, Jablonska S. Childhood scleroderma and its peculiarities. Cutis 1996;58:141-4; 148-52.
19. Krishnamurthy V, Porkodi R, Ramakrishnan S, et al. Progressive systemic sclerosis in south India. J Assoc Physicians India 1991;39:254-7.
20. Pelkonen PM, Jalanko HJ, Lantto K, et al. Incidence of systemic connective tissue diseases in children: A nationwide prospective study in Finland. J Rheumatol 1994;21:2143-6.
21. Cassidy JT, Sullivan DB, Dabich L, Petty RE. Scleroderma in children. Arthritis Rheum 1977;20:351-4.
22. Suarez-Almazor ME, Catoggio LJ, Maldonado-Cocco JA, Cuttica R, Garcia-Morteo O. Juvenile progressive systemic sclerosis: clinical and serologic findings. Arthritis Rheum 1985;28:699-702.
23. Lababidi HM, Nasr FW, Khatib Z. Juvenile progressive systemic sclerosis: report of five cases. J Rheumatol 1991;18:885-8.
24. Garty BZ, Athreya BH, Wilmott R, Scarpa N, Doughty R, Douglas SD. Pulmonary functions in children with progressive systemic sclerosis. Pediatrics 1991;88:1161-7.
25. Martinez-Cordero E, Fonseca MC, Aquilar Leon DE, Padilla A. Juvenile systemic sclerosis. J Rheumatol 1993;20:405-7.
26. Foeldvari I, Zhavania M, Birdi N, et al. Favourable outcome in 135 children with juvenile systemic sclerosis: results of a multi-national survey. Rheumatology Oxford 2000;39:556-9.
27. Bernstein RM, Pereira RS, Holden AJ, Black CM, Howard A, Ansell BM. Autoantibodies in childhood scleroderma. Ann Rheum Dis 1985;44:503-6.
28. Vancheeswaran R, Black CM, David J, et al. Childhood-onset scleroderma: is it different from adult-onset disease? Arthritis Rheum 1996;39:1041-9.
29. Martini G, Foeldvari I, Russo A, et al. Systemic scleroderma syndrome (SSS) in children: Clinical and immunological characteristics of 181 patients [abstract]. Arthritis Rheum 2003;48 Suppl:S512.
30. Okano Y. Antinuclear antibody in systemic sclerosis (scleroderma). Rheum Dis Clin North Am 1996;22:709-35.
31. Follansbee W, Zerbe T, Medsger T. Cardiac and skeletal muscle disease in systemic sclerosis (scleroderma): A high risk association. Am J Heart 1993;125:194-203.
32. Quartier P, Bonnet D, Gournet JC, et al. Severe cardiac involvement in children with systemic sclerosis and myositis. J Rheumatol 2002;29:1767-73.